Kiora Pharmaceuticals Inc (KPRX) — Strategic Asset Allocation Index
Kiora Pharmaceuticals Inc (KPRX) has a Strategic Asset Allocation Index of 0.7% as of June 2023. Strategic assets (PP&E of $95.10K plus long-term investments of $-) total $95.10K, measured against net assets of $13.64 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See KPRX equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Kiora Pharmaceuticals Inc Strategic Asset Allocation Index (2018–2021)
This chart shows how Kiora Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2018 to 2021. As of June 2023, the index stands at 0.7%, representing strategic assets of $95.10K against net assets of $13.64 Million USD. For live market cap and overall valuation, see Kiora Pharmaceuticals Inc market cap and net worth.
Annual Strategic Asset Allocation Index for Kiora Pharmaceuticals Inc (2018–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Kiora Pharmaceuticals Inc from 2018 to 2021, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See KPRX book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 1.9% | $283.41K | $283.41K | $- | $14.58 Million | ▲ +1.6 pp |
| 2020 | 0.3% | $30.57K | $30.57K | $- | $9.73 Million | ▲ +0.1 pp |
| 2019 | 0.3% | $16.85K | $16.85K | $- | $6.62 Million | ▼ -0.2 pp |
| 2018 | 0.5% | $43.52K | $43.52K | $- | $8.94 Million | — |